ALXN - Alexion Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Annual

Balance Sheet

All numbers in thousands
Breakdown
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Assets
Current Assets
Cash
Cash And Cash Equivalents
1,365,500
584,400
966,000
1,010,111
Short Term Investments
198,300
889,700
327,000
374,904
Total Cash
1,563,800
1,474,100
1,293,000
1,385,015
Net Receivables
922,300
726,500
650,000
532,832
Inventory
472,500
460,400
375,000
289,874
Other Current Assets
-
0
0
0
Total Current Assets
3,385,000
2,953,900
2,578,000
2,425,349
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
1,471,500
1,325,400
1,036,000
697,025
Accumulated Depreciation
-219,300
-160,300
-193,000
-176,131
Net property, plant and equipment
1,471,500
1,325,400
1,036,000
697,025
Equity and other investments
-
-
-
-
Goodwill
5,037,400
5,037,400
5,037,000
5,047,885
Intangible Assets
3,641,300
3,954,400
4,303,000
4,707,914
Other long-term assets
396,700
312,200
299,000
255,057
Total non-current assets
10,546,900
10,629,400
10,675,000
10,707,881
Total Assets
13,931,900
13,583,300
13,253,000
13,133,230
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Total Revenue
343,800
167,400
167,000
175,000
Accounts Payable
698,200
710,200
572,000
460,708
Taxes payable
-
-
-
-
Accrued liabilities
476,600
509,600
399,000
335,658
Deferred revenues
-
15,900
37,000
20,504
Other Current Liabilities
132,000
59,000
47,000
62,038
Total Current Liabilities
1,174,000
952,500
823,000
718,250
Non-current liabilities
Long Term Debt
2,501,700
2,720,700
2,888,000
3,281,250
Deferred taxes liabilities
391,100
365,000
396,000
528,990
Deferred revenues
-
-
-
-
Other long-term liabilities
338,800
309,100
219,000
194,817
Total non-current liabilities
3,592,600
3,737,700
3,736,000
4,156,364
Total Liabilities
4,766,600
4,690,200
4,559,000
4,874,614
Stockholders' Equity
Common Stock
0
0
0
23
Retained Earnings
2,325,800
2,242,100
1,818,000
1,180,395
Accumulated other comprehensive income
-9,700
-34,400
60,000
62,301
Total stockholders' equity
9,165,300
8,893,100
8,694,000
8,258,616
Total liabilities and stockholders' equity
13,931,900
13,583,300
13,253,000
13,133,230